Listen: Who discovered GLP-1? Plus: BrainStorm at the FDA and biotech’s slump
Listen: Why was chemist Svetlana Mojsov edged out of credit for discovering GLP-1? How did BrainStorm's day at the FDA go? And why is biotech still in a slump? Find…
When is negative data positive enough? Who gets credit for scientific breakthroughs? And wasn’t biotech supposed to bounce back?
We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain the story of Svetlana Mojsov, a chemist who played a vital role in the discovery of GLP-1 who has spent decades fighting for proper recognition. We also discuss the latest news in the life sciences, including the FDA hearing on a BrainStorm Cell Therapeutics’ polarizing ALS treatment, the end of the road for a once-vaunted drug developer, and the sorry state of biotech stocks.
What's Your Reaction?
